Palliation of Bone Cancer Pain by Antagonists of Platelet-Activating Factor Receptors

Bone cancer pain is the most severe among cancer pain and is often resistant to current analgesics. Thus, the development of novel analgesics effective at treating bone cancer pain are desired. Platelet-activating factor (PAF) receptor antagonists were recently demonstrated to have effective pain re...

Descripción completa

Detalles Bibliográficos
Autores principales: Morita, Katsuya, Shiraishi, Seiji, Motoyama, Naoyo, Kitayama, Tomoya, Kanematsu, Takashi, Uezono, Yasuhito, Dohi, Toshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956712/
https://www.ncbi.nlm.nih.gov/pubmed/24637403
http://dx.doi.org/10.1371/journal.pone.0091746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956712/
https://www.ncbi.nlm.nih.gov/pubmed/24637403
http://dx.doi.org/10.1371/journal.pone.0091746

Ejemplares similares